Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service
"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS
Ergebnis verändern
- Publikationstyp
Publikationstyp- Thema
- erschienen in
- Verlag
- Geographic terms
- Sprache
- 1
- 2
- 3
-
4
von Lincoff, AM ; Brown-Frandsen, K ; Colhoun, HM ; et al.
New England Journal of Medicine , 389 (24) pp. 2221-2232. (2023)
Schlagworte: Humans; Cardiovascular Diseases; Diabetes Mellitus; Type 2; Double-Blind Method; Glucagon-Like Peptides; Hypoglycemic Agents; Myocardial Infarction; Obesity; Overweight; Stroke; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptide-1 Receptor Agonists; Cardiovascular Agents
-
5
von Lingvay, I ; Brown-Frandsen, K ; Colhoun, HM ; et al.
Obesity , 31 (1) pp. 111-122. (2023)
Schlagworte: Female; Humans; Male; Middle Aged; Cardiovascular Diseases; Diabetes Mellitus; Type 2; Hypoglycemic Agents; Myocardial Infarction; Obesity; Overweight; Peripheral Arterial Disease; Stroke
-
6
von McKeigue, PM ; Porter, D ; Hollick, RJ ; et al.
Scandinavian Journal of Rheumatology ; volume 52, issue 4, page 412-417 ; ISSN 0300-9742 1502-7732
-
7
von Aizawa, K ; Casanova, F ; Gates, PE ; et al.
Hypertension , 78 (1) pp. 40-50. (2021)
Schlagworte: Aging; blood pressure; cardiovascular disease; hemodynamics; risk factor
-
8
von Timmons, JG ; Greenlaw, N ; Boyle, JG ; et al.
Diabetes, Obesity and Metabolism , 23 (6) pp. 1371-1378. (2021)
- 9
-
10
von Ryan, DH ; Lingvay, I ; Colhoun, HM ; et al.
American Heart Journal , 229 pp. 61-69. (2020)
-
11
von van Zuydam, NR ; Ladenvall, C ; Voight, BF ; et al.
Schlagworte: blood pressure; coronary artery disease; diabetes mellitus; genome-wide association study; risk factors
-
12
von Colhoun, HM ; Leiter, LA ; Mueller-Wieland, D ; et al.
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Cardiovascular System & Cardiology; Alirocumab; PCSK9; Diabetes mellitus; Non-HDL-C; HDL-C; Triglycerides; ODYSSEY; DM-DYSLIPIDEMIA; Type 2 diabetes; Usual care; ESC/EAS GUIDELINES; POOLED ANALYSIS; RISK; ASSOCIATION; MANAGEMENT; INTERVENTION; REDUCTION; RATIONALE; DESIGN; SAFETY
-
13
von Petrie, JR ; Chaturvedi, N ; Ford, I ; et al.
Presented at: The 54th Annual Meeting of the European Association for the Study of Diabetes, Berlin, Germany. (2018) (In press).
- 14
- 15
-
16
von Collaboration, CTT ; Reith, C ; Preiss, D ; et al.
Schlagworte: Clinical Trials and Supportive Activities; Diabetes; Clinical Research; Prevention; 6 Evaluation of treatments and therapeutic interventions; 6.1 Pharmaceuticals; Cardiovascular; Metabolic and endocrine
-
17
von Magliano, DJ ; Chen, L ; Morton, JI ; et al.
Schlagworte: Adolescent; Adult; Age of Onset; Australia; Diabetes Mellitus; Type 1; Type 2; Female; Humans; Incidence; Male; Young Adult
- 18
-
19
von Ray, KK ; Del Prato, S ; Mueller-Wieland, D ; et al.
10 ; 1
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Cardiovascular System & Cardiology; Alirocumab; Atherosclerotic cardiovascular disease; Type 2 diabetes mellitus; Low-density lipoprotein cholesterol; Dyslipidemia; SAFETY; EFFICACY; RISK; Cardiovascular System & Hematology; 1102 Cardiorespiratory Medicine and Haematology
-
20
von Ray, KK ; Colhoun, HM ; Szarek, M ; et al.
628 ; 618
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Endocrinology & Metabolism; MYOCARDIAL-INFARCTION; GENETIC-VARIANTS; STATIN THERAPY; BLOOD-GLUCOSE; RISK; PCSK9; ASSOCIATION; LIRAGLUTIDE; GUIDELINES; EVOLOCUMAB; ODYSSEY OUTCOMES Committees and Investigators
- 21
-
22
von Weir-McCall, JR ; Brown, L ; Summersgill, J ; et al.
Schlagworte: arteriosclerosis; atherosclerosis; cardiovascular diseases; hypertension; magnetic resonance angiography; pulse wave analysis
- 23
-
24
von Ray, KK ; Leiter, LA ; Mueller-Wieland, D ; et al.
1489 ; 1479
Schlagworte: Science & Technology; Life Sciences & Biomedicine; Endocrinology & Metabolism; mixed dyslipidaemia; non-HDL cholesterol; PCSK9; type 2 diabetes; DENSITY-LIPOPROTEIN CHOLESTEROL; PCSK9 INHIBITOR EVOLOCUMAB; CARDIOVASCULAR EVENTS; GENETIC-VARIANTS; POOLED ANALYSIS; AMG 145; EFFICACY; SAFETY; RISK; METAANALYSIS; 1103 Clinical Sciences
-
25
von Read, SH ; Van Diepen, M ; Colhoun, HM ; et al.
urn:ISSN:0149-5992 ; urn:ISSN:1935-5548 ; Diabetes Care, 41, 9, 2010-2018
Schlagworte: 32 Biomedical and Clinical Sciences; 4202 Epidemiology; 4203 Health Services and Systems; 4206 Public Health; 42 Health Sciences; 3202 Clinical Sciences; Heart Disease; Aging; Health Disparities; Diabetes; Cardiovascular; Health Disparities and Racial or Ethnic Minority Health Research; Prevention; Metabolic and endocrine; 3 Good Health and Well Being; Adult; Aged; 80 and over; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus; Type 2; Diabetic Angiopathies; Diagnostic Techniques; Endocrine; Female; Humans; Male; Middle Aged; Prognosis
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag